| I don't have a horse in the race. I just think you're not reading these documents carefully or considering the evidence carefully. For example, that case you cite above, the $6k copay. OK. Read the memo closely. A Walgreens exec is emailing a Turing exec citing a patient's problem with Turing's bureaucracy. How was the problem resolved? Did Turing pay? You say that CLEARLY Turing didn't end up paying in this particular case, because you hate Turing, but the document doesn't say. And you have no idea. Neither do I, but I'm not pretending. Generally: Turing says, for goodwill, they give away 60% of the drug for a dollar. Do you know of even one case where someone - verifiably - fell through the cracks and Turing refused to EVER pay? Are you opposed to the idea of pharmaceutical companies selling orphan drugs at high prices ($100k, $300k, or more)? Or are you only opposed to Turing's purchase of Daraprim and raising the price? Would you still oppose them if, in 10 years, it turned out Turing's profits had, e.g., produced a PKAN drug? Do you know a better way than high drug prices to incentivize the creation of drugs for serious rare diseases? |